|
|
|
Volumn 89, Issue 6, 2004, Pages 751-752
|
|
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma
a
|
|
Author keywords
ABVD; Hodgkin's lymphoma; Modified Stanford V
|
|
Indexed keywords
BLEOMYCIN;
CHLORMETHINE;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
ETOPOSIDE;
LOMUSTINE;
MELPHALAN;
PREDNISONE;
VINBLASTINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG DOSE REGIMEN;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
HODGKIN DISEASE;
HUMAN;
INTERMETHOD COMPARISON;
LEUKEMOGENESIS;
MALE;
PROGNOSIS;
RISK ASSESSMENT;
SIDE EFFECT;
STANFORD V REGIMEN;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
DOXORUBICIN;
ETOPOSIDE;
FEMALE;
HODGKIN DISEASE;
HUMANS;
MALE;
MECHLORETHAMINE;
MIDDLE AGED;
PREDNISONE;
REMISSION INDUCTION;
SURVIVAL ANALYSIS;
VINBLASTINE;
VINCRISTINE;
|
|
EID: 3042664519
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (8)
|
